Evidence behind this recommendation.
Selected studies from our library that inform the recommendations on this page. Evidence grade shown when available.
Acupuncture for chronic urticaria: a systematic review and meta-analysis with trial sequential analysis
“Meta-analysis with trial sequential analysis confirms the efficacy of acupuncture as an adjuvant to antihistamines in chronic urticaria, with significant reduction in UAS7 and improvement in quality of life.”
Acupuncture for allergic disorders: mast cell modulation via inflammatory pathway suppression
“Review of mast cell stabilization mechanisms by acupuncture: suppression of inflammatory pathways, reduction of IgE and histamine, and rebalancing of Th1/Th2 cytokines.”
What Chronic Urticaria Is
Chronic urticaria (CU) is defined by the presence of urticaria (erythematous, pruritic wheals), angioedema, or both for more than 6 weeks, with or without an identifiable trigger. Chronic spontaneous urticaria (CSU) — without a specific physical stimulus — is the most common form, accounting for 80–90% of CU cases.
The prevalence of CU is 0.5–1% of the general population, with a mean duration of 1–5 years and spontaneous remission in only 50% of cases at 1 year. It predominantly affects women (2:1 ratio) between 20 and 50 years of age. The impact on quality of life is profound: constant pruritus, the unpredictability of flares, and recurrent angioedema (especially labial and periorbital) generate significant anxiety, insomnia, and impairment in occupational and social activities.
Pathophysiology of Chronic Spontaneous Urticaria
Anti-FcεRI / anti-IgE autoantibodies
In ~45% of CSU cases, IgG autoantibodies against the high-affinity IgE receptor (FcεRI) or against IgE itself activate mast cells and basophils — autoimmune mechanism
Hyperreactive dermal mast cell
Reduced activation threshold; spontaneous degranulation with release of histamine, prostaglandins, leukotrienes, TNF-α, and IL-31
Histamine and vasodilation
Histamine binds to H1 receptors on endothelial cells and sensory nerves; vasodilation + increased permeability → erythematous wheal and dermal edema
Pruritus via IL-31 and neuropeptides
IL-31 released by mast cells activates pruriceptive C fibers; substance P amplifies mast cell degranulation — positive feedback loop
Triggering factors
Stress, acute viral infections, NSAIDs, foods (in a minority), temperature variations, and menstruation may precipitate flares — without being the primary cause of CSU
Diagnosis and Assessment
- UAS7 (Urticaria Activity Score × 7 days, 0–42): sum of urticaria intensity score + pruritus over 7 consecutive days — standard in clinical trials
- CU-Q2oL (Chronic Urticaria Quality of Life Questionnaire): assesses impact on daily life
- BSST (Basophil Sensitivity Test) and analysis of anti-FcεRI IgG: identifies the autoimmune component in CSU
- Elevated D-dimer: associated with greater severity and refractoriness to treatment in CSU
- Exclusion of inducible urticaria (pressure, cold, heat, solar, dermographism): specific provocation tests
Conventional Treatments
Treatment of CU follows the EAACI/BSACI pyramid: second-generation H1 antihistamines as the foundation, with dose escalation up to 4× and the addition of omalizumab for refractory cases.
THERAPEUTIC APPROACHES IN CHRONIC URTICARIA
| APPROACH | EFFICACY | LIMITATIONS | COMPATIBLE WITH ACUPUNCTURE? |
|---|---|---|---|
| 2nd-generation anti-H1 (cetirizine, loratadine, fexofenadine) | Moderate to high; control in 50–60% at standard dose; mandatory first line | Incomplete response in 40%; requires continuous daily use | Yes — no described pharmacological interactions; dose adjustments are the dermatologist/allergist decision |
| Anti-H1 at increased dose (up to 4×) | High in 50–65% of patients; without proportional increase in adverse effects | Residual drowsiness in some; tachyphylaxis possible | Yes — acupuncture as an adjuvant for symptom control, without replacing the anti-H1 |
| Omalizumab (anti-IgE) 300 mg/month | Very high for refractory CSU; 65–75% complete control at 12 weeks | High cost; monthly injection; discontinuation leads to relapse in the majority | Yes — can be performed concurrently; there is no robust evidence that it prolongs the response to omalizumab |
| Cyclosporine (severe refractory cases) | High; reserved for severe CSU without response to anti-H1 + omalizumab | Immunosuppression; monitoring of renal function and blood pressure | Yes — acupuncture as quality-of-life support |
| Medical acupuncture | Moderate as an adjuvant; UAS7 −9.8 in combination with anti-H1 | Does not replace antihistamine; better outcome in CSU with a stress component | Integrates a multimodal protocol with excellent tolerability |
How Medical Acupuncture Works in Chronic Urticaria
Medical acupuncture acts on CSU through multiple immunological and neuroendocrine mechanisms: mast cell stabilization via the autonomic nervous system, reduction of circulating IgE, decrease in plasma histamine, and modulation of the stress component that precipitates flares.
DOCUMENTED EFFECTS OF ACUPUNCTURE ON CSU
Clinical Studies
Randomized trials evaluated acupuncture in combination with antihistamines, demonstrating consistent additive benefits in flare frequency, pruritus, and quality of life.
CLINICAL OUTCOMES — ALLERGY ASTHMA IMMUNOL RES 2019 (N=72, 12 WEEKS)
What the Studies Show
- Acupuncture + anti-H1 superior to anti-H1 alone in UAS7, flare frequency, and quality of life
- Meta-analysis of 7 RCTs confirms superiority of the combination (SMD −0.68 for UAS7)
- Complete remission (UAS7 = 0) in 38% vs. 21% in the control group — clinically relevant
- Reduction of IgE and plasma histamine described in studies — suggests an immunomodulatory effect, still to be confirmed by larger trials
- Better response in CSU with stress identified as a trigger — profile of greatest benefit
Modern Approach: Integrative Acupuncture in Chronic Urticaria
Medical acupuncture integrates into the CU protocol as an adjuvant to antihistamines, acting especially on the neuroinflammatory component and on the management of stress as a trigger of flares.
Integrative Protocol for Chronic Spontaneous Urticaria
Maintenance of antihistamine (mandatory base)
2nd-generation anti-H1 at a regular dose — never discontinue without medical guidance; acupuncture is an adjuvant, not a substitute for anti-H1 in active CSU
Intensive acupuncture phase (weeks 1–8)
Acupuncture 1–2×/week; protocol SP-10+LI-11+ST-36+SP-6+LI-4+ST-40+GV-14; weekly monitoring of UAS7
Reassessment and adjustment (week 8)
If UAS7 <7 (well-controlled CSU): maintain biweekly acupuncture and discuss gradual reduction of anti-H1 with the dermatologist; if UAS7 ≥16: consider omalizumab
Maintenance (after week 12)
Monthly acupuncture for relapse prevention; continuous stress management; identification and control of triggering factors; anti-H1 adjusted according to disease activity
When to See a Medical Acupuncturist
CSU with a partial response to antihistamines and a stress component identified as a trigger is the ideal indication to integrate medical acupuncture into treatment.
Profiles With the Best Response to Acupuncture
- CSU with partial control by antihistamine (UAS7 7–16) — seeking additional improvement
- CSU with emotional stress identified as a trigger of exacerbations
- CSU with anxiety and insomnia associated with chronic pruritus
- CSU in a phase of attempted gradual reduction of antihistamine dose with medical supervision
- CSU with episodic angioedema without an allergic component (hereditary ruled out) — for flare prevention
Frequently Asked Questions
Frequently Asked Questions
No — H1 antihistamines are the irreplaceable foundation of treatment for active CSU. Discontinuation of the anti-H1 without medical guidance can precipitate severe flares. Acupuncture improves control when added to the anti-H1, and may make a gradual dose reduction feasible in responding patients — always under the supervision of the dermatologist or allergist.
Most responders notice a reduction in the frequency and intensity of flares between the 4th and 6th session. More consolidated benefit after 8–12 weeks. The standard protocol is 12 weeks (1–2×/week initially, then biweekly). Weekly monitoring of UAS7 guides progression.
For chronic recurrent angioedema associated with CSU, acupuncture may contribute to reducing the frequency of episodes by stabilizing mast cells and reducing IgE. It has no role in the management of acute angioedema. Angioedema without urticaria (suspected hereditary angioedema due to C1-INH deficiency) requires specific immunological investigation before any other treatment.
CSU has spontaneous remission in ~50% of cases at 1 year and ~80% at 5 years. Acupuncture does not "cure" CSU definitively, but may contribute to stabilizing the condition, prolonging periods of remission, and making a reduction in pharmacological burden feasible during the natural course of the disease. Sustained remission is the realistic clinical goal.
Yes — acupuncture can be performed during urticaria flares without active wheals at the needle insertion site. The antiallergic protocol (SP-10, LI-11, LI-4) may have an immediate antipruritic effect during the session. Severe flares with extensive angioedema or significant discomfort are first managed with anti-H1 and, if necessary, corticosteroid — before resuming the acupuncture session.